Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 8/2019

08.12.2018 | Review paper

Imaging and Surgical Treatment of Primary Pulmonary Artery Sarcoma

verfasst von: Moritz C. Wyler von Ballmoos, Edward Y. Chan, Michael J. Reardon

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Primary pulmonary artery sarcoma is a rare tumor originating from the pulmonary artery tree. Given the low incidence, few centers have reported on more than a handful of cases. Because of its rarity it is also commonly misdiagnosed as pulmonary embolism. Multi-modality diagnostic imaging and recognition of specific imaging characteristics along with a high index of suspicion is required to make the correct diagnosis and expedite treatment. The primary imaging modality for most cardiac tumors such as primary pulmonary artery sarcoma is now MRI. It provides superb spatial resolution as well as functional assessment of the heart and pulmonary circulation. CT imaging also is part of routing imaging and remains as the most pertinent imaging modality to evaluate the lung parenchyma and presence of metastatic disease. Here we review the pertinent imaging modalities and tissue characteristics that facilitate recognition of primary pulmonary artery sarcoma. We also provide a short overview of surgical resection and reconstruction, which is the mainstay therapy, for this rare tumor.
Literatur
1.
Zurück zum Zitat Blackmon SH, Rice DC, Correa AM et al (2009) Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87:977–984CrossRefPubMed Blackmon SH, Rice DC, Correa AM et al (2009) Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87:977–984CrossRefPubMed
2.
Zurück zum Zitat Kaminaga T, Takeshita T, Kimura I (2003) Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. Eur Radiol 13(Suppl 4):L1–L10CrossRefPubMed Kaminaga T, Takeshita T, Kimura I (2003) Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. Eur Radiol 13(Suppl 4):L1–L10CrossRefPubMed
3.
Zurück zum Zitat Vander Salm TJ (2000) Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg 12:89–100CrossRefPubMed Vander Salm TJ (2000) Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg 12:89–100CrossRefPubMed
4.
Zurück zum Zitat Gulati G, Sharma S, Kothari SS, Juneja R, Saxena A, Talwar KK (2004) Comparison of echo and MRI in the imaging evaluation of intracardiac masses. Cardiovasc Intervent Radiol 27:459–469CrossRefPubMed Gulati G, Sharma S, Kothari SS, Juneja R, Saxena A, Talwar KK (2004) Comparison of echo and MRI in the imaging evaluation of intracardiac masses. Cardiovasc Intervent Radiol 27:459–469CrossRefPubMed
5.
Zurück zum Zitat Kauczor HU, Schwickert HC, Mayer E, Kersjes W, Moll R, Schweden F (1994) Pulmonary artery sarcoma mimicking chronic thromboembolic disease: computed tomography and magnetic resonance imaging findings. Cardiovasc Intervent Radiol 17:185–189CrossRefPubMed Kauczor HU, Schwickert HC, Mayer E, Kersjes W, Moll R, Schweden F (1994) Pulmonary artery sarcoma mimicking chronic thromboembolic disease: computed tomography and magnetic resonance imaging findings. Cardiovasc Intervent Radiol 17:185–189CrossRefPubMed
6.
Zurück zum Zitat Cox JE, Chiles C, Aquino SL, Savage P, Oaks T (1997) Pulmonary artery sarcomas: a review of clinical and radiologic features. J Comput Assist Tomogr 21:750–755CrossRefPubMed Cox JE, Chiles C, Aquino SL, Savage P, Oaks T (1997) Pulmonary artery sarcomas: a review of clinical and radiologic features. J Comput Assist Tomogr 21:750–755CrossRefPubMed
7.
Zurück zum Zitat Smith WS, Lesar MS, Travis WD et al (1989) MR and CT findings in pulmonary artery sarcoma. J Comput Assist Tomogr 13:906–909CrossRefPubMed Smith WS, Lesar MS, Travis WD et al (1989) MR and CT findings in pulmonary artery sarcoma. J Comput Assist Tomogr 13:906–909CrossRefPubMed
8.
Zurück zum Zitat Rafal RB, Nichols JN, Markisz JA (1995) Pulmonary artery sarcoma: diagnosis and postoperative follow-up with gadolinium-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. Mayo Clin Proc 70:173–176CrossRefPubMed Rafal RB, Nichols JN, Markisz JA (1995) Pulmonary artery sarcoma: diagnosis and postoperative follow-up with gadolinium-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. Mayo Clin Proc 70:173–176CrossRefPubMed
9.
Zurück zum Zitat Dennie CJ, Veinot JP, McCormack DG, Rubens FD (2002) Intimal sarcoma of the pulmonary arteries seen as a mosaic pattern of lung attenuation on high-resolution CT. AJR Am J Roentgenol 178:1208–1210CrossRefPubMed Dennie CJ, Veinot JP, McCormack DG, Rubens FD (2002) Intimal sarcoma of the pulmonary arteries seen as a mosaic pattern of lung attenuation on high-resolution CT. AJR Am J Roentgenol 178:1208–1210CrossRefPubMed
10.
Zurück zum Zitat Choi EY, Yoon YW, Kwon HM et al (2004) A case of pulmonary artery intimal sarcoma diagnosed with multislice CT scan with 3D reconstruction. Yonsei Med J 45:547–551CrossRefPubMed Choi EY, Yoon YW, Kwon HM et al (2004) A case of pulmonary artery intimal sarcoma diagnosed with multislice CT scan with 3D reconstruction. Yonsei Med J 45:547–551CrossRefPubMed
11.
Zurück zum Zitat Ricou F, Nicod PH, Moser KM, Peterson KL (1991) Catheter-based intravascular ultrasound imaging of chronic thromboembolic pulmonary disease. Am J Cardiol 67:749–752CrossRefPubMed Ricou F, Nicod PH, Moser KM, Peterson KL (1991) Catheter-based intravascular ultrasound imaging of chronic thromboembolic pulmonary disease. Am J Cardiol 67:749–752CrossRefPubMed
12.
Zurück zum Zitat Esakof DD, Schneider AT, Pandian NG et al (1993) Delineation of pulmonary artery sarcoma with multiplane and panoramic transesophageal echocardiography. J Am Soc Echocardiogr 6:619–623CrossRefPubMed Esakof DD, Schneider AT, Pandian NG et al (1993) Delineation of pulmonary artery sarcoma with multiplane and panoramic transesophageal echocardiography. J Am Soc Echocardiogr 6:619–623CrossRefPubMed
13.
14.
Zurück zum Zitat Coskun U, Sinan UY, Calpar I et al (2014) Pulmonary artery sarcoma masquerading as chronic pulmonary thromboembolism. Tex Heart Inst J 41:518–522CrossRefPubMedPubMedCentral Coskun U, Sinan UY, Calpar I et al (2014) Pulmonary artery sarcoma masquerading as chronic pulmonary thromboembolism. Tex Heart Inst J 41:518–522CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Srivali N, Yi ES, Ryu JH (2017) Pulmonary artery sarcoma mimicking pulmonary embolism: a case series. QJM 110:283–286PubMed Srivali N, Yi ES, Ryu JH (2017) Pulmonary artery sarcoma mimicking pulmonary embolism: a case series. QJM 110:283–286PubMed
16.
Zurück zum Zitat Kruger I, Borowski A, Horst M, de Vivie ER, Theissen P, Gross-Fengels W (1990) Symptoms, diagnosis, and therapy of primary sarcomas of the pulmonary artery. Thorac Cardiovasc Surg 38:91–95CrossRefPubMed Kruger I, Borowski A, Horst M, de Vivie ER, Theissen P, Gross-Fengels W (1990) Symptoms, diagnosis, and therapy of primary sarcomas of the pulmonary artery. Thorac Cardiovasc Surg 38:91–95CrossRefPubMed
17.
Zurück zum Zitat Chan EY, Reul RM, Kim MP, Reardon MJ (2018) The “Texas Two-Step” procedure. J Thorac Cardiovasc Surg 155:285–287CrossRefPubMed Chan EY, Reul RM, Kim MP, Reardon MJ (2018) The “Texas Two-Step” procedure. J Thorac Cardiovasc Surg 155:285–287CrossRefPubMed
Metadaten
Titel
Imaging and Surgical Treatment of Primary Pulmonary Artery Sarcoma
verfasst von
Moritz C. Wyler von Ballmoos
Edward Y. Chan
Michael J. Reardon
Publikationsdatum
08.12.2018
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 8/2019
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-018-1489-8

Weitere Artikel der Ausgabe 8/2019

The International Journal of Cardiovascular Imaging 8/2019 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.